Effect of Disrupting N -Methyl-d-aspartate Receptor–Postsynaptic Density Protein-95 Interactions on the Threshold for Halothane Anesthesia in Mice
Open Access
- 1 May 2008
- journal article
- laboratory investigations
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 108 (5) , 882-887
Abstract
Background: The authors' previous studies have shown that clinically relevant concentrations of inhalational anesthetics dose-dependently and specifically inhibit the PSD-95, Dlg, and ZO-1 (PDZ) domain-mediated protein interactions between postsynaptic density protein 95 (PSD-95) and N-methyl-d-aspartate receptors, and that the knockdown of spinal PSD-95 by intrathecal injection of PSD-95 antisense oligodeoxynucleotide significantly reduces the minimum alveolar anesthetic concentration for isoflurane in rats. Methods: The authors constructed a fusion peptide, Tat-PSD-95 PDZ2, comprising the second PDZ domain of PSD-95, which can specifically disrupt PSD-95 PDZ2-mediated protein interactions by binding to its interaction partner. By intraperitoneal injection of this fusion peptide into mice, the authors investigated the effect of disrupting the PSD-95 PDZ2-mediated protein interactions on the threshold for halothane anesthesia. Results: Systemically injected fusion peptide Tat-PSD-95 PDZ2 was delivered into the central nervous system, disrupted the protein-protein interactions between N-methyl-d-aspartate receptor NR2 subunits and PSD-95, and significantly reduced the minimum alveolar anesthetic concentration and righting reflex EC50 for halothane. Conclusions: By disrupting PSD-95 PDZ2 domain-mediated protein interactions, intraperitoneal injection of cell-permeant fusion peptide Tat-PSD-95 PDZ2 dose-dependently reduces the threshold for halothane anesthesia. These results suggest that PDZ domain-mediated protein interactions at synapses in the central nervous system might play an important role in the molecular mechanisms of halothane anesthesia.Keywords
This publication has 25 references indexed in Scilit:
- Nitrous oxide (N 2 O) requires the N -methyl- d -aspartate receptor for its action in Caenorhabditis elegansProceedings of the National Academy of Sciences, 2004
- Halothane Anesthesia Affects NMDA-Stimulated Cholinergic and GABAergic Modulation of Striatal Dopamine Efflux and Metabolism in the Rat In VivoNeurochemical Research, 2004
- Synaptic PDZ Domain-mediated Protein Interactions Are Disrupted by Inhalational AnestheticsJournal of Biological Chemistry, 2003
- Propofol-Induced Anesthesia in Mice Is Mediated by γ-Aminobutyric Acid-A and Excitatory Amino Acid ReceptorsAnesthesia & Analgesia, 2003
- Protein transduction technology offers novel therapeutic approach for brain ischemiaTrends in Pharmacological Sciences, 2003
- Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in ratsNeuroscience, 2003
- Protein transduction technologyCurrent Opinion in Biotechnology, 2002
- Ligand Binding of the Second PDZ Domain Regulates Clustering of PSD-95 with the Kv1.4 Potassium ChannelJournal of Biological Chemistry, 2002
- TAT-Mediated Protein Transduction into Mammalian CellsMethods, 2001
- Genetic enhancement of inflammatory pain by forebrain NR2B overexpressionNature Neuroscience, 2001